Edition:
United States

RTI Surgical Inc (RTIX.OQ)

RTIX.OQ on NASDAQ Stock Exchange Global Select Market

4.45USD
20 Sep 2018
Change (% chg)

$0.10 (+2.30%)
Prev Close
$4.35
Open
$4.40
Day's High
$4.45
Day's Low
$4.40
Volume
65,039
Avg. Vol
26,522
52-wk High
$5.05
52-wk Low
$3.90

Latest Key Developments (Source: Significant Developments)

RTI Surgical Outlines 2018 Guidance And Long-Term Goals
Friday, 5 Jan 2018 07:00am EST 

Jan 5 (Reuters) - RTI Surgical Inc ::RTI SURGICAL OUTLINES 2018 GUIDANCE AND LONG-TERM GOALS.RTI SURGICAL INC - EXPECTS FULL YEAR REVENUES IN RANGE OF $280 MILLION AND $290 MILLION.RTI SURGICAL INC - ‍EXPECTS FULL YEAR EBITDA TO BE IN RANGE OF $32 MILLION TO $38 MILLION​.RTI SURGICAL - CO TO EXPAND REVENUE TO MORE THAN $500 MILLION​ AS ‍LONG-TERM FINANCIAL GOAL, EXPECTED TO BE ACHIEVED WITHIN FIVE YEARS.RTI SURGICAL - CO TO ‍DOUBLE EBITDA MARGIN TO MORE THAN 20 PERCENT AS LONG TERM FINANCIAL GOAL, EXPECTED TO BE ACHIEVED WITHIN FIVE YEARS ​.  Full Article

RTI Surgical Announces Acquisition Of Zyga Technology
Thursday, 4 Jan 2018 04:30pm EST 

Jan 4 (Reuters) - RTI Surgical Inc ::RTI SURGICAL ANNOUNCES ACQUISITION OF ZYGA TECHNOLOGY, INC..RTI SURGICAL INC - TERMS OF DEAL WERE NOT DISCLOSED..RTI SURGICAL - CO TO FUND DEAL WITH CASH AND BORROWING UNDER EXISTING CREDIT FACILITY.  Full Article

RTI Surgical receives warning letter from FDA
Tuesday, 14 Nov 2017 08:26am EST 

Nov 14 (Reuters) - RTI Surgical Inc :On Nov 9, co received a warning letter from FDA resulting from an inspection of co's facility in Alachua, Florida in April.Warning letter relates to processes used in manufacture of map3 cellular allogeneic bone graft product ​.Warning letter also relates to FDA's views with respect to map3 allograft's regulatory classification​.Warning letter does not restrict production, marketing, or distribution of map3 allograft​.Intends to conduct clinical studies that further confirm safety and efficacy of map3(reg) allograft​.  Full Article

RTI Surgical Q3 earnings per share $0.23
Thursday, 2 Nov 2017 07:30am EDT 

Nov 2 (Reuters) - RTI Surgical Inc ::RTI Surgical announces 2017 third quarter results.Q3 earnings per share $0.23.Q3 earnings per share view $0.01 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $0.05 to $0.07.Sees FY 2017 earnings per share $0.21 to $0.23.Q3 adjusted earnings per share $0.01 excluding items.Sees FY 2017 revenue $274 million to $280 million.Q3 revenue $66.7 million versus I/B/E/S view $65.4 million.FY 2017 earnings per share view $0.06, revenue view $277.8 million -- Thomson Reuters I/B/E/S.  Full Article

RTI names Jonathon Singer as Chief Financial and Administrative Officer​
Monday, 18 Sep 2017 06:22pm EDT 

Sept 18 (Reuters) - RTI Surgical Inc ::RTI Surgical continues to augment leadership team to accelerate its strategic direction.‍RTI board member Jonathon Singer named Chief Financial and Administrative Officer​.‍CFO Robert Jordheim will leave company to pursue new endeavors following successful transition​.Jonathon Singer will resign from board.  Full Article

RTI Surgical Inc enters into a third amended and restated loan agreement​
Wednesday, 9 Aug 2017 06:29am EDT 

Aug 9 (Reuters) - RTI Surgical Inc :RTI Surgical Inc says ‍on August 3, 2017 company entered into a third amended and restated loan agreement​ - SEC filing.2017 loan agreement provides for a revolving credit facility in aggregate principal amount of $42.5 million​.Total of $35.0 million currently is outstanding on revolving credit facility​.2017 loan agreement also contains a term loan facility in aggregate principal amount of $25.4 million​.  Full Article

RTI Surgical posts Q2 loss of $0.04 per share
Tuesday, 8 Aug 2017 08:00am EDT 

Aug 8 (Reuters) - RTI Surgical Inc :RTI Surgical announces 2017 second quarter results.Sees FY 2017 adjusted earnings per share $0.04 to $0.08 excluding items.Sees FY 2017 earnings per share $0.00 to $0.04.Q2 adjusted earnings per share $0.02.Q2 loss per share $0.04.Sees FY 2017 revenue $274 million to $280 million.Q2 revenue $72.1 million versus I/B/E/S view $69.9 million.Q2 earnings per share view $0.02 -- Thomson Reuters I/B/E/S.  Full Article

RTI Surgical divests cardiothoracic closure business to A&E Medical Corp
Thursday, 3 Aug 2017 04:49pm EDT 

Aug 3 (Reuters) - RTI Surgical Inc :RTI Surgical divests cardiothoracic closure business to A&E Medical Corporation for up to $60 million.RTI Surgical Inc - sale proceeds will pay down a portion of company's debt and support strategic investments as RTI extends its credit facilities.RTI Surgical Inc - deal for $54 million in cash plus an additional $6 million in contingent cash consideration..  Full Article

RTI Surgical Q1 revenue $69.9 million
Thursday, 27 Apr 2017 08:00am EDT 

April 27 (Reuters) - Rti Surgical Inc :Rti surgical® announces 2017 first quarter results.Q1 revenue $69.9 million.Sees fy 2017 adjusted earnings per share $0.05 to $0.10 excluding items.Sees fy 2017 earnings per share $0.01 to $0.06.Q1 loss per share $0.05.Fy2017 earnings per share view $0.08, revenue view $280.2 million -- Thomson Reuters I/B/E/S.  Full Article

RTI Surgical expands line of tissue matrices in international markets
Tuesday, 18 Apr 2017 09:00am EDT 

April 18 (Reuters) - RTI Surgical Inc :Announces expansion of its extensive line of tissue matrices in international markets.  Full Article

UPDATE 1-Barry Callebaut to boost Ivory Coast cocoa grinding capacity

ABIDJAN, May 22 Switzerland's Barry Callebaut plans to boost the annual grinding capacity of its facilities in Ivory Coast to 230,000 tonnes from 170,000 tonnes by 2022, CEO Antoine de Saint-Affrique said on state-owned broadcaster RTI.